Latest papers

Myxomatous stromal changes and necrosis of bone marrow--a retrospective study of 3 years.

Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis.

Sequence mapping of the Californian MSW strain of Myxoma virus.

Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.

Atypical myxomatosis--virus isolation, experimental infection of rabbits and restriction endonuclease analysis of the isolate.

Lessons in détente or know thy host: the immunomodulatory gene products of myxoma virus.

Study of localised dermatosis in rabbits caused by myxomatosis.

Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. III. Release, persistence and rate of spread of an identifiable strain of myxoma virus.

Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. I. Natural occurrence of myxomatosis.

Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. II. Selection of a strain of virus for release.

Researchers as guinea pigs.

Occurrence of atypical myxomatosis in Central Europe: clinical and virological examinations.

A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation.

Epidemiology of viral haemorrhagic disease and myxomatosis in a free-living population of wild rabbits.

Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins.

Immune responses to myxoma virus.

[Myxomatosis in the rabbit]

Patterns of parasite aggregation in the wild European rabbit (Oryctolagus cuniculus).

Biological control of the rabbit in Australia: lessons not learned?

First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease.